Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents

British Journal of Pharmacology

Volumn 121, Issue 8, 1997, Pages 1513-1522

  Field, M J ^a   Oles, R J ^a   Lewis, A S ^a   McCleary, S ^a   Hughes, J ^a   Singh, L ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

2 subunit of voltage dependent calcium channels; Carrageenan; Formalin; Side effects; Thermal and mechanical hyperalgesia

Indexed keywords

4 AMINOBUTYRIC ACID DERIVATIVE; CALCIUM CHANNEL; CARRAGEENAN; FORMALDEHYDE; GABAPENTIN; MORPHINE; NALOXONE; PREGABALIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATAXIA; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG CROSS TOLERANCE; ENANTIOMER; GASTROINTESTINAL MOTILITY; HYPERALGESIA; INFLAMMATION; INTRATHECAL DRUG ADMINISTRATION; MALE; MORPHINE TOLERANCE; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; SEDATION; SUBCUTANEOUS DRUG ADMINISTRATION;

ACETIC ACIDS; AMINES; ANALGESICS; ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CYCLOHEXANECARBOXYLIC ACIDS; DISCRIMINATION LEARNING; DRUG TOLERANCE; GAMMA-AMINOBUTYRIC ACID; GASTROINTESTINAL MOTILITY; HYPERALGESIA; MALE; MORPHINE; NALOXONE; RATS; RATS, SPRAGUE-DAWLEY; STEREOISOMERISM;

EID: 0030796031     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701320     Document Type: Article

References (40)

1. BARTOSZYK, G.D. & REIMANN, W. (1985). Preclinical characterization of the anticonvulsant gabapentin. 16th Epilepsy International Congress, Abstracts, 1.
2. BRUST, P.F., SIMERSON, S., MCCUE, A.F., DEAL, C.R., SCHOONMAKER, S., WILLIAMS, M.E., VELICELEBI, G., JOHNSON, E.C., HARPOLD, M.M. & ELLIS, S.B. (1993). Human neuronal voltage-dependent calcium channels: studies on subunit structure and role in channel assembly. Neuropharmacology, 32, 1089-1102.
3. DIAZ, A. & DICKENSON, A.H. (1997). Blockade of spinal N- and P-type, but not L-type, calcium channels inhibits the excitability of rat dorsal horn neurones produced by subcutaneous formalin inflammation. Pain, 69, 93-100.
4. DICKENSON, A.H. & SULLIVAN, A.F. (1987). Peripheral origins and central modulation of subcutaneous formalin-induced activity of rat dorsal horn neurones. Neurosci. Lett., 83, 207-211.
5. DUBUISSON, D. & DENNIS, S.G. (1977). The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain, 4, 161-174.
6. GAUR, S., NEWCOMB, R., RIVNAY, B., BELL, J.R., YAMASHIRO, D., RAMACHANDRAN, J. & MILJANICH, G.P. (1994). Calcium channel antagonist peptides define several components of transmitter release in the hippocampus. Neuropharmacology, 32, 1211-1219.
7. 2δ subunit of a calcium channel. J. Biol. Chem., 271, 5768-5776.
8. GOA, K.L. & SORKIN, E.M. (1993). Gabapentin: A review of its pharmacological properties and clinical potential in epilepsy. Drug Evaluation, 46, 409-427.
9. 2δ subunit in current stimulation and subunit interaction. Neuron, 16, 431-440.
10. HARGREAVES, K., DUBNER, R., BROWN, F., FLORES, C. & JORIS, J. (1988). A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain, 32, 77-88.
11. 2+ channel diversity. Annu. Rev. Neurosci., 17, 399-418.
12. ISOM, L.L., DE JONGH, K.S. & CATTERALL, W.A. (1994). Auxiliary subunits of voltage-gated ion channels. Neuron, 12, 1183-1194.
13. KAYSER, V. & GUILBAUD, G. (1987). Local and remote modifications of nociceptive sensitivity during carrageenan-induced inflammation in the rat. Pain, 28, 99-108.
14. MALMBERG, A.B. & YAKSH, T.L. (1994). Voltage-sensitive calcium channels in spinal nociceptive processing: blockade of N- and P-type channels inhibits formalin-induced nociception. J. Neurosci., 14, 4882-4890.
15. MCCALL, W.D, TANNER, K.D. & LEVINE, J.D. (1996). Formalin induces biphasic activity in C-fibers in the rat. Neurosci. Letts, 208, 45-48.
16. MCCLEAN, M.J. (1995). Gabapentin. Epilepsia, 36(Suppl. 2), S73-S86.
17. MELLER, S.T., CUMMINGS, C.J., TRAUB, R.J. & GEBHART, G.F. (1994). The role of nitric oxide in the development and maintenance of hyperalgesia produced by intraplantar carrageenan in the rat. Neuroscience, 60, 367-374.
18. MELLER, S.T. & GEBHART, G.F. (1994). Spinal mediators of hyperalgesia. Drugs, 47, 10-20.
19. MELLER, S.T., PECHMAN, P.S., GEBHART, G.F. & MAVES, T.J. (1992). Nitric oxide mediates the thermal hyperalgesia produced in a model of neuropathic pain in the rat. Neuroscience, 50, 7-10.
20. MELLICK, G.A., MELLICY, L.B. & MELLICK, L.B. (1995). Gabapentin in the management of reflex sympathetic dystrophy. J. Pain Symptom Management, 10, 265-266.
21. OLIVERA, B.M., MILJANICH, G.P., RAMACHANDRAN, J. & ADAMS, M.E. (1994). Calcium channel diversity and neurotransmitter release: the omega-conotoxins and omega-agatoxins. Annu. Rev. Biochem., 63, 823-867.
22. RAMSAY, R.E. (1994). Clinical efficacy and safety of gabapentin. Neurology, 44(Suppl. 5), S23-S30.
23. RANDALL, L.O. & SELITTO, J.J. (1957). A method for measurement of analgesic activity on inflamed tissue. Arch. Int. Pharmacodyn., 111, 409-419.
24. SINGH, L., FIELD, M.J., FERRIS, P., HUNTER, J.C., OLES, R.J., WILLIAMS, R.G. & WOODRUFF, G.N. (1996a). The antiepileptic agent gabapentin (Neurotonin) possesses anxiolytic-like and antinociceptive actions that are reversed by D-serine. Psychopharmacology, 127, 1-9.
25. SINGH, L., OLES, R.J., FIELD, M.J., ATWAL, P., WOODRUFF, G.N. & HUNTER, J.C. (1996b). Effect of CCK receptor antagonists on the antinociceptive, reinforcing and gut motility properties of morphine. Br. J. Pharmacol., 118, 1317-1325.
26. STANFA, L.C., SULLIVAN, A.F. & DICKENSON, A.H. (1992). Alterations in neuronal excitibility and the potency of spinal mu, delta and kappa opioids after carrageenan-induced inflammation. Pain, 50, 345-354.
27. 3H]gabapentin binding to a novel site in the rat brain: homogenate binding studies. Eur. J. Pharmacol. Molec. Pharmacol. Sec., 244, 293-301.
28. TAYLOR, C.P., VARTANIAN, M.G., YUEN, P., BIGGE, C., SUMANCHAUHAN, N. & HILL, D.R. (1993). Potent and stereospecific anticonvulsant activity of 3-isobutyl GABA relates to in vitro binding at a novel site labeled by tritiated gabapentin. Epilepsy Res., 14, 11-15.
29. TRICKLEBANK, M.D., SINGH, L., OLES, R.J., PRESTON, C. & IVERSEN, S.D. (1989). The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor. Eur. J. Pharmacol., 167, 127-135.
30. TURNER, T.J., ADAMS, M.E. & DUNLAP, K. (1992). Calcium channels coupled to glutamate release identified by ω-aga-IVA. Science, 258, 310-313.
31. 2+ channel types coexist to regulate synaptosomal neurotransmitter release. Proc. Natl. Acad. Sci. U.S.A., 90, 9518-9522.
32. UCHITEL, O.D., PROTTI, D.A., SANCHEZ, V., CHERKSEY, B.D., SUGIMORI, M. & LLINAS, R. (1992). P-type voltage-dependent calcium channel mediates presynaptic calcium influx and transmitter release in mammalian synapses. Proc. Natl. Acad. Sci. U.S.A., 89, 3330-3333.
33. WHEELER-ACETO, H. & COWAN, A. (1991). Standardization of the rat paw formalin test for the evaluation of analgesics. Psychopharmacology, 104, 35-44.
34. WHEELER-ACETO, H., PORRECA, F. & COWAN, A. (1990). The rat paw formalin test: comparison of noxious agents. Pain, 40, 229-238.
35. 2, β subunits of a novel human neuronal calcium channel subtype. Neuron, 8, 71-84.
36. WINTER, C.A. & FLATAKER, L. (1965). Reaction thresholds to pressure in oedematous hind paw of rats: response to analgesic drugs. J. Pharmacol. Exp. Ther., 148, 373-379.
37. WOOLF, C.J. (1983). Evidence for a central component of post-injury pain hypersensitivity. Nature, 306, 686-688.
38. WOOLF, C.J. (1994). A new strategy for the treatment of inflammatory pain: prevention or elimination of central sensitization. Drugs, 47, 1-9.
39. WOOLF, C.J. & WALL, P.D. (1986). Relative effectiveness of C-primary afferent fibers of different origins in evoking a prolonged facilitation of the flexor reflex in the rat. J. Neurosci., 6, 1433-1442.
40. XIAO, W. & BENNETT, G.I. (1995). Gabapentin relieves abnormal pains in a rat model of painful peripheral neuropathy. Soc. Neurosci. Abstr., 21, 356.